IDH2 and angioimmunoblastic T-cell lymphoma: Lemonnier et al. [36] demonstrated that mutant IDH2 expression was restricted to the malignant T-cell component, and that 2-hydroxyglutarate (2HG) was elevated in lymphoma tissue and serum of AITL patients.